Gonadotropins and estradiol responses to single intranasal or subcutaneous administration of a luteinizing hormone-releasing hormone agonist in the early follicular phase.

[1]  N. Faure,et al.  Gonadotroph and corpus luteum responses to two successive intranasal doses of a luteinizing hormone-releasing hormone agonist at different days after the midcycle luteinizing hormone surge. , 1983, Fertility and sterility.

[2]  N. Faure,et al.  Sensitivity of luteinizing hormone and gonadal steroid responses to single intranasal administration of an LHRH agonist (Hoe-766) in young normal adult men , 1982, Journal of endocrinological investigation.

[3]  G Quesnel,et al.  Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonist. , 1982, Fertility and sterility.

[4]  W. Vale,et al.  "Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis. , 1982, The Journal of clinical endocrinology and metabolism.

[5]  N. Faure,et al.  Sensitivity of pituitary and corpus luteum responses to single intranasal administration of (D-ser[TBU]6-des-gly-NH2(10)) luteinizing hormone-releasing hormone ethylamide (Buserelin) in normal women. , 1982, Fertility and sterility.

[6]  R. Casper,et al.  Luteal phase defects induced by an agonist of luteinizing hormone-releasing factor: a model for fertility control , 1982 .

[7]  W. Crowley,et al.  Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report. , 1981, The New England journal of medicine.

[8]  W. Crowley,et al.  Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty. , 1981, The Journal of clinical endocrinology and metabolism.

[9]  R. Casper,et al.  Effects of a superactive luteinizing hormone-releasing factor agonist on gonadotropin and ovarian function during the menstrual cycle. , 1979, American journal of obstetrics and gynecology.

[10]  A. Schally,et al.  Levels of luteinizing hormone (LH), follicle-stimulating hormone, and 17 beta-estradiol in response to D-Trp6-LH-releasing hormone during different phases of the menstrual cycle in normal women. , 1978, Fertility and sterility.

[11]  H. Taubert,et al.  The effect of D-ser (TBU)6-LH-RH-EA10 upon gonadotropin release in normally cyclic women. , 1977, The Journal of clinical endocrinology and metabolism.

[12]  A. Schally,et al.  Stimulation of luteinizing hormone (LH) and follicle-stimulating hormone by (D-Leu6, des-Gly10-NH2)-LH-releasing hormone ethylamide after subcutaneous, intravaginal, and intrarectal administration to women. , 1977, Fertility and sterility.

[13]  Pérez-López Fr,et al.  Induced prolactin release in women under long-term medroxyprogesterone acetate treatment. , 1975 .

[14]  R. Rebar,et al.  Variation of pituitary responsiveness to synthetic LRF during different phases of the menstrual cycle. , 1972, The Journal of clinical endocrinology and metabolism.

[15]  L. Wide,et al.  VARIATION IN LH AND FSH RESPONSE TO LH‐RELEASING HORMONE DURING THE MENSTRUAL CYCLE , 1972, The Journal of obstetrics and gynaecology of the British Commonwealth.

[16]  L. Wide,et al.  Early follicular phase luteinizing hormone-releasing hormone agonist administration - effects on follicular maturation and corpus luteum function in women. , 1982, Contraception.

[17]  M. Schmidt-gollwitzer,et al.  The contraceptive use of Buserelin a potent LHRH agonist: clinical and hormonal findings. , 1981 .

[18]  A. Corbin,et al.  Physiology and contraceptive effects of LHRH and agonistic analogs in female animals. , 1981 .

[19]  Coutinho Em,et al.  Effect of LHRH on ovulation and corpus luteum formation in women. , 1981 .

[20]  F. Labrie,et al.  Luteolytic activity of LHRH and [D-Ser(TBU)6, des-Gly-NH2(10)]LHRH ethylamide: a new and physiological approach to contraception in women. , 1980, International journal of fertility.

[21]  R. Casper,et al.  Gonadotropin-estradiol responses to a superactive luteinizing hormone-releasing hormone agonist in women. , 1980, The Journal of clinical endocrinology and metabolism.

[22]  C. Bergquist,et al.  Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men. , 1980, International journal of fertility.

[23]  P. Kelly,et al.  Inhibitory effects of treatment with LHRH or its agonists on ovarian receptor levels and function. , 1979, Advances in experimental medicine and biology.

[24]  A. Schindler,et al.  Dose-response study with a new LH-RH analogue, D-Ser (TBU)6 LH-RH 1-9 (EA)10 during the follicular phase of the menstrual cycle. , 1978, Acta endocrinologica.